There is no card. There is no $50 fee.
There is nothing to sign up for.
LB1235, as introduced, would have created a patient registry. A committee amendment removed the registry requirement entirely before passage. Sen. John Cavanaugh framed the removal as a patient protection — it kept the state from holding a list of cannabis patients.
So if a website is offering to "register" you for a Nebraska medical marijuana card, ask what exactly you are paying for. We are not naming or accusing anyone. We are telling you what the State of Nebraska does and does not operate, so you can ask the question yourself.
Medical Cannabis Commission application window for manufacturing licenses:
September 14, 2026 · 11:59 p.m. CDTSame day: a public Commission meeting, 1:00–3:00 PM, 301 Centennial Mall South, 1st Floor Hearing Room, Lincoln. Quoted from mcc.nebraska.gov on 2026-09-09. Confirm on their page before acting.
How a Nebraska patient is actually supposed to qualify
Not a card. Not a registry. A piece of paper from your own practitioner.
| What the law requires | Detail |
|---|---|
| A written recommendation | From a health care practitioner, stating that in their professional judgment "the potential benefits of cannabis outweigh the potential harms for the alleviation of a patient's medical condition, its symptoms, or side effects of the condition's treatment" |
| Signed and dated | By the practitioner |
| Valid for | Two years from issuance, unless the practitioner specifies a different period |
| Possession limit | Up to 5 ounces — not counting the weight of other ingredients combined with cannabis in topicals, food, drink or other preparations |
| Fee to the state | None. There is no state patient fee, because there is no state patient process. |
That is the whole patient side of the law. It is simpler than most states — and it has one single point of failure.
The single point of failure
Everything above depends on a practitioner willing to sign. Cannabis remains federally illegal, and Nebraska practitioners had no explicit state-law protection for writing such a recommendation.
LB933, introduced by Sen. John Cavanaugh, would have provided it — shielding providers from criminal, civil, or disciplinary penalties solely for issuing a recommendation. It expressly would not have shielded them from malpractice or negligence claims, and they would have remained responsible for a proper patient evaluation.
What happened to it — the record, in order
| Step | What happened |
|---|---|
| Introduced | Sen. John Cavanaugh (Omaha) |
| First round | Advanced. A Cavanaugh amendment removed the protection against civil penalties and discipline for malpractice or professional negligence. |
| Second round, 1st | Cavanaugh amendment setting standards a practitioner must meet before recommending (evaluate the condition, weigh benefits and harms, discuss risks, get consent; no discounts, samples or payments tied to a dispensary). Failed 20–20. 25 votes were needed. |
| Second round, 2nd | Sen. Hardin amendment requiring practitioners to be Nebraska-licensed and to comply with the Medical Cannabis Regulation Act. Adopted 25–12. |
| Second round, 3rd | Sen. Kathleen Kauth (Omaha) amendment requiring recommendations to rest on professional judgment and scientific evidence that benefits outweigh harms. Adopted 26–16. |
| Second round, 4th | Sen. Kauth offered a second amendment adding provisions of her bill LB732, on hormones and puberty blockers for Nebraskans under 19 experiencing gender dysphoria. Sen. George Dungan challenged it as not germane; the challenge was unsuccessful. It was never voted on. |
| Outcome | Cavanaugh asked that the bill be passed over, and the Legislature moved on “without voting on the bill or the pending amendments.” With four legislative days left in the 60-day session, it was not rescheduled. Dead for 2026. |
Source for every row above: Unicameral Update, “Legal protections for medical cannabis recommendations passed over,” 2026-04-07 (the Legislature’s own news service).
This table was wrong in three ways, and we are saying exactly how. Before today it read: “Second round: Sen. Kathleen Kauth (Omaha) attached her separate bill, LB732 … Unrelated to cannabis,” followed by “Cavanaugh’s amendment: Failed 20–20.”
1. Wrong order. The 20–20 vote came first, before LB732 was offered. Our table made it look like a reaction to LB732. 2. “Attached” was wrong. The LB732 amendment was offered and never voted on. 3. We left out a fact that cuts toward Sen. Kauth’s side: a challenge to the amendment’s germaneness was unsuccessful. We had also called LB732 “unrelated to cannabis” in our own voice. That was a characterization, and it is gone.
How we found it: Sen. Kauth’s statement below says the amendment was ruled germane. We checked that against the Legislature’s own account the same day, and the account also showed our order was wrong. Asking the person named is how this page got more accurate.
"Poison pill" and "hijacked" are their words, not ours, and they are quoted as characterizations by interested parties. The neutral, checkable fact is this: at second reading, one of Cavanaugh’s amendments failed on a tied vote; two other amendments were adopted; then an amendment on a different subject was offered, survived a germaneness challenge, and was pending when the bill was pulled. It was never rescheduled. We are not telling you what that means. The sequence is on the record and dated.
Both sides, stated fairly: offering amendments is a normal and lawful legislative tool used by members of every party, and an amendment ruled germane is allowed under the Legislature’s rules. Sen. Kauth’s underlying bill is a separate policy question this page takes no position on. The earlier 20–20 vote also means twenty senators declined to support that Cavanaugh amendment. That is not one person’s doing.
We asked her, and she answered. On 2026-09-09 we emailed Sen. Kauth's office at her published legislative address, described exactly what this page says and how it is framed, and invited her to explain the intent behind the amendment or to correct anything inaccurate.
She replied on 2026-09-09, about 90 minutes after the request, and asked to see the whole section. It was sent to her, word for word, the same day. Her statement arrived on 2026-09-11. It is published here in full and unedited, exactly as she sent it:
“I do not support giving physicians immunity from liability for any care provided. Sen. Cavanaugh’s original bill was much stronger with providing immunity, and through debate the focus narrowed and the level of immunity decreased. Because the topic of 933 addressed what doctors could and could not provide for treatment - my bill LB 732 was germane and relevant as it also addressed what doctors could and could not provide for treatment, but for different reasons.
Amending bills onto others is a standard practice at that stage of debate and is allowed if the topics are germane. LB732 was deemed germane by the Presiding Officer and allowed. Because LB933 had been adjusted, I felt the trade off of passing it would be justifiable if LB732 were to pass with it. I was very surprised that Sen. Cavanaugh abandoned the medical cannabis community and that bill because of LB732 - which protects children from cross-sex hormones and puberty blockers until they are adults. Rather than being a poison pill - I had hoped to get protections for children included - making it a hard pill to swallow but acceptable.”
— Sen. Kathleen Kauth, District 31, by email, 2026-09-11A comment is not an endorsement of this page, and this page does not respond to it here. Her point about the germaneness ruling led to the correction above.
The same offer stands with Sen. Cavanaugh, who was written to on the same day and is quoted above in his own words. Sen. Kauth’s statement describes his decision, so he will get the same space, on the same terms, in the same kind of box. If one senator’s comment ends up with more room on this page than the other’s, the page has picked a side by layout.
What it adds up to
2024-11-05 — 71% of Nebraskans vote to legalize medical cannabis.
2024–2026 — the Secretary of State who certified the petitions, the Attorney General, and a former state senator litigate for two years to void them. They lose 7–0.
2026-04-02 — LB1235 passes 46–2. Signed by Gov. Pillen 2026-04-07. The Commission is restructured; the registry is removed.
2026-04 — LB933, the bill protecting practitioners who write recommendations, is passed over while an amendment on a different subject is pending. Dead for the session.
Reported as of April 2026: no patients in Nebraska had received medical cannabis recommendations, more than a year after legalization.
Five ounces is the legal possession limit for a patient with a recommendation. The recommendation is the only door. And the lock on that door is a bill that died on the floor.
That is the timeline. You decide what it means.
The business side — where the state is moving
| Item | Figure | Source |
|---|---|---|
| Manufacturing applications close | 2026-09-14, 11:59 PM CDT | state (MCC) |
| Application fee | "There is currently no fee to submit an application" | state (NLCC) |
| Maximum fee the Commission may set | $50,000 for license applications, registrations and renewals | LB1235 |
| Commission member salary | $12,500/year | LB1235 |
| Background check | Fingerprint-based national criminal history check for initial applicants | LB1235 |
| Ownership | Majority owned by U.S. citizen(s) resident in Nebraska ≥ 4 years | state (NLCC) |
| Dispensary licenses, year one | Up to 20, at least one per congressional district | trackers |
| Cultivation licenses, year one | Up to 10 | trackers |
Note the shape of that table. The rows sourced to the state and to LB1235 are about businesses. There is no patient row, because the state does not run a patient process. The commercial system is being built on schedule. The patient pathway is the part that stalled.
The qualifying conditions
- ALS
- Autism with frequent or severe self-injurious or aggressive behavior
- Cancer
- Crohn's disease
- Ulcerative colitis
- Epilepsy
- Glaucoma
- Hepatitis C (with nausea or cachexia)
- HIV/AIDS
- Huntington's disease
- Parkinson's disease
- PTSD
- Spinal cord injury
- Terminal illness
- Serious conditions causing severe nausea or cachexia
- Long-lasting severe or chronic pain that has not responded to other, non-opioid treatments
Multiple sclerosis is not named. Neither is fibromyalgia, migraine, arthritis, anxiety, depression, or ADHD.
The last item — long-lasting severe or chronic pain that has not responded to non-opioid treatments — is a catch-all that may or may not reach a given case. Whether it reaches yours is a clinical judgment by your practitioner. It is not something this page can tell you, and it is not something any website should tell you. This list is sourced to trackers and should be read against the statute itself — see homework below.
Still federally illegal
A state law does not change federal law. Cannabis remains a federally controlled substance. A Nebraska practitioner's recommendation does not fix: federal employment and security clearances; federally subsidized housing; firearms purchases — the ATF Form 4473 question is federal; crossing state lines with product; or banking for the businesses involved.
This is not legal advice and it is not a complete list. "Legal in Nebraska" and "legal" are different sentences.
Homework still owed on this page
- Read LB1235's enrolled text directly. Our registry finding comes from the Legislature's own Unicameral Update and floor reporting — good sources, but the enrolled bill is better. The PDF did not extract cleanly on 2026-09-09.
- Quote the qualifying-conditions list and the 5-ounce limit from the statute, not from trackers.
- Confirm the "no patients have received recommendations" figure with a current count. That was reported around April 2026 and this page is dated September. It may have changed, and we have not checked. It is flagged here rather than repeated as if current.
Ask Sen. Kauth's office for a statement on the LB732 amendment.DONE 2026-09-09 — asked, awaiting reply. Both-sides means asking, not assuming.- Ask Sen. Cavanaugh's office as well. He is quoted on this page and is entitled to expand on his own words, not just be characterized by them.
Three requests went out on 2026-09-09. Two have answered.
| Who | What we asked | Status |
|---|---|---|
| NE Medical Cannabis Commission | Confirm or correct our reading that LB1235 removed the patient registry requirement; and whether there is public comment at the 09-14 meeting | REPLIED 2026-09-10. Public comment: yes, no advance signup needed. Agenda: posted at mcc.nebraska.gov/meeting-information at least 24 hours before. On the registry: “the Commission is unable to provide an interpretation of the law or legal advice regarding the requirements described in your question.” So our registry finding stays sourced to the Legislature, not the Commission. |
| Sen. Kathleen Kauth (Dist. 31) | The intent behind the LB732 amendment to LB933, and whether anything on this page is inaccurate | REPLIED 2026-09-09; STATEMENT 2026-09-11, published in full above. It led to a dated correction of our timeline. |
| Sen. John Cavanaugh (Dist. 9) | Whether he will reintroduce LB933, whether our summary of his registry rationale is fair, and any current recommendation count | No response as of 2026-09-11 |
Two of three have answered. Where a row still says "no response," the request is two days old, so it means "we have not waited long yet," not anything about the recipient. Legislative offices run thin between sessions. These rows get updated with real dates as time passes. Whatever comes back — including nothing — gets published here. A dated silence is a fact. It is not an accusation, and we will not write it as one.
Beta means incomplete. It never means fake. #PROOF — trust, but verify. Including us.